Background Behavioural, cognitive, and pharmacological interventions can all be effective
for insomnia. However, because of inadequate resources, medications are more frequently …

Introduction There have been no previous meta-analytic studies that have looked at the
prevalence of insomnia symptoms in different COVID-19 groups using a single assessment …

The COVID-19 pandemic, on a global scale, has prompted multifaceted challenges,
including a notable psychological toll on the general population. This study uses mixed …

Despite cognitive behaviour therapy for insomnia (CBT‐I) being the first‐line intervention for
the disorder, it is often not readily available to patients in need. The stepped care model …

With thorough coverage of inequality in health care access and practice across the field it
surveys, The Sociology of Health, Healing, and Illness is widely acclaimed by instructors as …

Background Insomnia is a risk factor for affective disorders. This study examined whether
individuals with insomnia symptoms early in the pandemic, either pre-existing or new-onset …

The world‐wide prevalence of insomnia disorder reaches up to 10% of the adult population.
Women are more often afflicted than men, and insomnia disorder is a risk factor for somatic …

Background Pharmacological treatment is common in practice and widely used for the
management of insomnia. However, evidence comparing the relative effectiveness, safety …

Importance The association of multiple healthy sleep dimensions with post–COVID-19
condition (PCC), also known as long COVID, has not been investigated. Objective To …

Thermoregulation and sleep are tightly coordinated, with evidence that impairments in
thermoregulation as well as increases in ambient temperature increase the risk of sleep …